Meeting
2023 ASCO Annual Meeting
Utilizing a two-step frailty assessment strategy in older adults with multiple myeloma (MM): A decision curve analysis.
Authors
Andrew Gahagan
Department of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
Andrew Gahagan , Monica Sai Pasala , Clare Ubersax , Abigail Tucker , Christian Harmon , Susan Bal , Kelly Nicole Godby , Gayathri Ravi , Luciano J. Costa , Grant Richard Williams , Smith Giri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 8061)
DOI
10.1200/JCO.2023.41.16_suppl.8061
Abstract #
8061
Poster Bd #
53
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
The impact of diabetes on the performance of skeletal muscle density (SMD) in screening for frailty: Findings from the Cancer and Aging Resilience Evaluation (CARE) Registry.
First Author: Sydney T Thai
Poster
2021 ASCO Annual Meeting
Impact of the G8 score on the outcome of a cohort of elderly patients with solid or hematological malignancies.
First Author: Federica Biello
Poster
2019 ASCO Annual Meeting
ELAN-ONCOVAL (Elderly Head and Neck Cancer-Oncology Evaluation) study: Evaluation of the G8 screening tool and the ELAN geriatric evaluation (EGE) for elderly patients (pts) with head and neck squamous cell carcinomas (HNSCC).
First Author: Cécile Mertens
Poster
2018 ASCO Annual Meeting
Utilizing a practical tablet-based modified geriatric assessment in clinic for older adults with multiple myeloma (MM).
First Author: Nitya Nathwani